De novo formation of testis tissue from single-cell suspensions allows manipulation of different testicular compartments before grafting to study testicular development and the spermatogonial stem cell niche. However, the low percentages of newly formed seminiferous tubules supporting complete spermatogenesis and lack of a defined protocol have limited the use of this bioassay. Low spermatogenic efficiency in de novo formed tissue could result from the scarcity of germ cells in the donor cell suspension, cell damage caused by handling or from hypoxia during tissue formation in the host environment. In this study, we compared different proportions of spermatogonia in the donor cell suspension and the use of Matrigel as a scaffold to support de novo tissue formation and spermatogenesis. Then, we used the system to investigate the role of vascular endothelial growth factor 165 (VEGF165) during testicular morphogenesis on blood vessel and seminiferous tubule formation, and on presence of germ cells in the de novo developed tubules. Our results show that donor cell pellets with 10!10 6 porcine neonatal testicular cells in Matrigel efficiently formed testis tissue de novo. Contrary to what was expected, the enrichment of the cell suspension with germ cells did not result in higher numbers of tubules supporting spermatogenesis. The addition of VEGF165 did not improve blood vessel or tubule formation, but it enhanced the number of tubules containing spermatogonia. These results indicate that spermatogenic efficiency was improved by the addition of Matrigel, and that VEGF165 may have a protective role supporting germ cell establishment in their niche.
Introduction
The formation of the male gonad begins in the early stages of embryogenesis and results in an environment capable to sustain spermatogenesis at puberty (Chen et al. 2005) . This supportive and instructive environment is constituted of Sertoli, peritubular myoid and Leydig cells together with the basement membrane and the vasculature compartment and it forms a niche for spermatogonial stem cells (SSC) to sustain a lifelong supply of gametes. Sertoli cells are major components of this environment, as they are in intimate contact with germ cells inside seminiferous tubules, being homogenously distributed and providing growth factors such as glial cell line-derived neurotrophic factor (GDNF), basic fibroblast growth factor (bFGF) and adhesion molecules maintaining SSC self-renewal (Naughton et al. 2006 , Kanatsu-Shinohara et al. 2008 . In contrast, undifferentiated spermatogonia are asymmetrically distributed, clustered adjacent to the vascular branch points and interstitial cells (ChiariniGarcia et al. 2001 , Yoshida et al. 2007 , indicating a role for the blood supply guiding niche orientation in the testis.
The proximity of SSCs to the interstitial vasculature indicated a role for the family of vascular endothelial growth factors (VEGF), more specifically VEGFA, which is the major promoter of physiological and pathological angiogenesis (Carmeliet 2003 , Byrne et al. 2005 and protects extra vascular cells from deleterious effects induced by hypoxia (Lambrechts et al. 2003) .
In the testis, VEGFA is important during early stages of development, promoting the formation of sex cords (Cool et al. 2011) . At postnatal stages, there is no active angiogenesis under physiological conditions. Nonetheless, Sertoli, Leydig, and peritubular myoid cells release VEGFA and display its receptors in different stages of testis development (Bott et al. 2006) .
The VEGFA synthesis by niche cells and the location of SSC closer to the vasculature make this factor worth further investigation for understanding the SSC niche. However, the study of SSCs and their niche in vivo is challenged by limitations in the available existing methods, especially in large mammalian species. To date, most of the knowledge was attained in rodents, and more data from other species is required to enable the accurate extrapolation of findings to higher mammals.
Testis tissue xenografting has been used to study male fertility in different mammalian species. It was the first method described to achieve full spermatogenesis from prepubertal donors after ectopic transplantation into immunocompromised mice (Honaramooz et al. 2002a,b) and since then it has been used to study or preserve male fertility (Honaramooz et al. 2004 , Ohta & Wakayama 2005 , Arregui et al. 2008 .
When testis tissue was treated with VEGF164 before tissue xenografting or added during tissue culture for 7 days before xenografting, the addition of VEGF164 resulted in a higher percentage of seminiferous tubules supporting spermatogenesis (Schmidt et al. 2006 ). This report was followed up by another manuscript investigating the role of VEGFA in testis development (Caires et al. 2009) , in which the addition of VEGF164 in tissue explants cultured in vitro increased the ratio of selected anti-apoptotic genes vs pro apoptotic genes in the tissue.
In testis tissue xenografting, the architecture of the tissue is preserved and cell associations are maintained, therefore the ability to study individual cell types and their interaction within the SSC niche is limited.
We previously reported de novo morphogenesis of functional testis tissue from isolated testicular somatic and germ cells. The cells obtained by enzymatic digestion from neonatal porcine testes, when transplanted under the dorsal skin of immunocompromised mice, were able to rearrange into a functional endocrine and spermatogenic unit, supporting complete maturation and development of haploid male gametes (Honaramooz et al. 2007) . Further reports described this morphogenic ability of isolated testis cells in different species such as rodents (Kita et al. 2007) , ovine (Arregui et al. 2008) and bovine (Zhang et al. 2008) donors and also in species used as model organisms, such as zebrafish (Kawasaki et al. 2010) and Xenopus (Kawasaki et al. 2006) .
There are many differences between xenografts of testicular tissue and de novo morphogenesis of testis tissue after grafting of isolated cells. Grafting of cells more likely subjects all testicular cells to the same exposure to growth factors, such as VEGFA, while the existing structure and cell associations present in tissue fragments may limit growth factor uptake to deeper areas of the tissue.
De novo morphogenesis of testis tissue allows for manipulation of different compartments of the testicular niche before tissue reassembly, giving this technique potential to be used to study signaling, orientation and guidance of the cells when forming the testis and to elucidate factors controlling spermatogenesis. However, most of the de novo formed tubules contain solely Sertoli cells leading to low spermatogenic efficiency, with the presence of elongated spermatids ranging from 10 to 20% in de novo formed seminiferous tubules (Honaramooz et al. 2007 , Kita et al. 2007 .
In this study, our goals were to overcome the low spermatogenic efficiency of the system by testing different conditions when transplanting porcine testicular cells and to test the de novo morphogenesis as a functional assay to study the aspects of testis function. We evaluated the development of grafts with different cell numbers, the percentage of germ cells and the use of Matrigel as a scaffold to maintain cells closer together.
The improved method was then tested as a functional assay to study the effect of VEGF165 on blood supply and reorganisation of the testis tissue.
Material and methods

Tissue enzymatic digestion
Testes from 1-week-old piglets were donated by a commercial farm (Sunterra Farms) in Strathmore, Alberta, Canada. The cells were harvested by a two-step enzymatic protocol previously described (Honaramooz et al. 2002a,b) . The final cell population was dived in two groups. One was kept refrigerated at 4 8C for 72 h until grafting surgery and the other one was submitted to differential plating for enrichment of germ cells.
Enrichment of germ cells
Briefly, 50!10 6 cells were plated into 100 mm tissue culture dishes (BD Bioscience, Mississauga, ON, Canada) in 15 ml DMEM (Life Technologies) with 5% foetal bovine serum (Thermo Scientific, Rochester, NY, USA) and incubated at 37 8C in 5% CO 2 in air. After 18 h, cells remaining in suspension and those slightly attached were removed by trypsinisation for 30 s with 1:10 dilution of 0.25% trypsin-EDTA (Gibco, Life Technologies) and plated in new flasks. This was repeated at 48 and 72 h after the initial plating. Cell recovery and viability were recorded, and immunocytochemistry using antibodies against UCHL1, an established marker to identify undifferentiated spermatogonia (Luo et al. 2009) , was used to identify germ cells (UCHL1 C , Vimentin K ) and somatic cells (UCHL1 K , Vimentin C ; see below).
Cell characterisation
The cells kept refrigerated and the enriched cell suspension used in all five replicates were characterised by immunocytochemistry with the following antibodies: mouse monoclonal anti-vimentin Cy3 (1:500, Sigma-Aldrich), mouse monoclonal anti-alpha-smooth muscle actin FITC conjugated (1:500, Sigma-Aldrich), mouse monoclonal anti-Gata4 (1:40, Santa Cruz Biotechnology), rabbit anti-human protein gene product 9.5 (UCHL1) (1:500, AbDSerotec, Raleigh, Canada), mouse monoclonal anti-P450c17 (1:500, kindly donated by Dr Alan Conley, University of California at Davis), primary antibodies incubations were followed by secondary antibodies: goat antirabbit Alexafluor 488 (1:400, Sigma-Aldrich) or donkey antimouse Alexafluor 555 (1:400, Sigma-Aldrich) to identify spermatogonia (UCHL1
) and myoid cells (alpha smooth muscle Actin C , Vimentin C ).
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After characterisation of both cell populations, four different groups were created.
Effect of germ cell number and extracellular matrix on spermatogenic efficiency in de novo formed testis tissue
The experimental design is outlined schematically in Fig. 1 . Four groups with different concentrations of spermatogonia and the scaffold Matrigel with reduced growth factors (MRGF) (BD Sciences, Bedford, MA, USA) were created:
Group 1 (control): 50!10 6 cells not enriched for spermatogonia (containing 3-4% spermatogonia) without MRGF; group 2: 50!10 6 cells not enriched for spermatogonia in 100 ml MRGF; group 3: 10!10 6 cells containing 25% spermatogonia in 100 ml MRGF; group 4: 10!10 6 cells not enriched for spermatogonia in 100 ml MRGF.
Immunodeficient recipient mice (26 NU/NCr, six SCID, Charles River, Wilmington, MA, USA) were castrated and groups were randomly assigned to one of four injection sites located under the dorsal skin, spaced between the shoulder and the rump. Our previous studies demonstrated that the immunocompromised strains of the recipients do not influence the development of de novo formed tissue (Honaramooz et al. 2007 , Arregui et al. 2008 .
The experiment was carried out in five replicates with different pools of testicular cells, to minimise any influence from the cell suspension, surgical procedure or batch of mice used on the observed results.
The care and use of research animals were approved by the Institutional Animal Care and Use Committee of the University of Calgary.
Sample recovery and processing
Mice from different surgery dates were randomly assigned to analysis at 24 and 40 weeks, data from both time points was combined to analyse each group. Mice were killed by CO 2 inhalation; grafts were recovered, fixed in Bouin's solution and stored in 70% ethanol until processing for histology. Grafts were embedded in paraffin and cut into 5 mm sections.
The reconstitution of functional spermatogenic tissue was assessed in cross sections from the central area of formed grafts by immunohistochemistry. UCHL1 was used to identify gonocytes and spermatogonia (Luo et al. 2009 ). Paraffin sections were dewaxed and dehydrated using xylene followed by a graded series of ethanol washes (100, 95, and 70% ethanol, 5 min each) and treated with 3% hydrogen peroxide in distilled H 2 O to block endogenous peroxidase activity and were incubated at room temperature in CAS-Block (Invitrogen) for 20 min to block non-specific antibody binding. These sections were incubated with anti-UCHL1 (1:500, AbDSerotec) as the primary antibody overnight at 4 8C and then with peroxidase-conjugated donkey anti-rabbit IgG (1:400, SigmaAldrich) as the secondary antibody for 1 h at room temperature. Peroxidase activity was detected using Vector NovaRED (Vector Laboratories, Burlington, ON, Canada) and tissue was counterstained with haematoxylin (Vector Laboratories).
Effect of VEGF165 on formation of testis tissue
One-week-old piglet testicular cells were obtained as described earlier and the cell suspension obtained was immediately divided into pellets of 10!10 6 cells mixed in 100 ml MRGF and assigned to two groups: VEGF165 treated: 10!10 6 cells mixed in 100 ml MRGF with 100 ng/ml of recombinant human VEGF165 (R&D Systems Minneapolis, MN, USA) and control: 10!10 6 cells mixed in 100 ml MRGF. Four-cell pellets per animal (three treated and one control) were randomly assigned to injection sites and ectopically grafted under the dorsal skin of 12 castrated immunocompromised mice (NU/NCr, Charles Rivers) in three sets of replicates.
Sample recovery and analysis
The cell aggregates were recovered after 12 weeks of transplantation; at this time point seminiferous cords are organised and germ cells are located on the basement membrane. Recovered grafts were fixed and processed as described earlier.
An antibody to alpha smooth muscle actin was used to label blood vessels after comparison with other markers, such as von Willerbrand factor (VWF), VE cadherin and CD31. VE cadherin is expressed in germ cells (Aivatiadou et al. 2007 ) and adhesion molecules of the cadherin family play a role in interaction amongst Leydig, Sertoli and germ cells (Byers et al. 1994) . CD31 is expressed in endothelial cells and leucocytes as well as murine primordial germ cells. Therefore, the use of these markers could lead to overestimate the number and location of blood vessel in the xenografts recovered. VWF expression in porcine tissue is not consistent in all tissues and blood vessels (Rand et al. 1987 , Giddings et al. 1997 .
The reliability of alpha smooth muscle actin to identify blood vessels was verified by immunohistochemistry in sequential cross sections from grafts recovered after 12 weeks, comparing CD31 and alpha smooth muscle actin. Paraffin sections from grafts recovered after 12 weeks were dewaxed and dehydrated as described earlier, incubated with CAS Block (Invitrogen) at room temperature for 20 min, followed by incubation overnight at 4 8C with FITC-conjugated mouse monoclonal anti-alpha smooth muscle actin (1:500, Sigma-Aldrich) or FITC-conjugated mouse anti-porcine CD31 (1:400, AbDSerotec). Both antibodies labeled the same structures; however, staining for alpha smooth muscle actin provided a clearer staining pattern making blood vessel counts easier and more reliable (Fig. 2) . Alpha smooth muscle actin is also present in peritubular myoid cells of the seminiferous tubule, therefore staining for alpha smooth muscle actin facilitated identification and measurement of newly formed seminiferous tubules as well as blood vessels.
Cross sections from the middle area of recovered grafts were analysed by double-staining immunohistochemistry for the detection of UCHL1 cells and alpha smooth muscle actin to identify undifferentiated spermatogonia and blood vessels respectively (Fig. 3) . The slides were treated with Bloxall (Vector Laboratories, Burlingame, CA, USA) to block the endogenous peroxidase and alkaline phosphatase activity, then CAS-Block (Invitrogen) was added for 20 min to block non-specific antibody binding. The samples were incubated with primary antibody UCHL1 (1:500, AbDSerotec) and antialpha smooth muscle actin (1:400, Sigma-Aldrich) overnight at 4 8C, followed by peroxidase-conjugated donkey anti-rabbit IgG (1:400, Sigma-Aldrich) as the secondary antibody. Peroxidase activity was detected using Vector NovaRED (Vector Laboratories), samples were then incubated with secondary alkaline phosphatase-conjugated goat anti-mouse IgA (1:400, AbDSerotec). Alkaline phosphatase activity was detected using the Vector Blue Alkaline Phosphatase Kit (Vector Laboratories), followed by counterstaining with VECTOR Methyl Green (Vector Laboratories).
Detection of apoptosis by the TUNEL assay
Paraffin-embedded cross sections from de novo formed tissue recovered after 12 weeks and 10-week-old testis tissue (positive control) were subjected to the DeadEnd Fluorometric TUNEL System assay according to manufacturer's instructions (Promega) to identify apoptotic cells.
Cell proliferation assay
Cross sections from the middle area of recovered grafts were analysed by immunohistochemistry for the detection of Ki67 to identify proliferative cells. The slides were subjected to heatinduced epitope retrieval in citrate buffer for 20 min at 95 8C, then for quenching of endogenous peroxidase activity the sections were incubated for 20 min in 3% H 2 O 2 followed by CAS-Block (Invitrogen) for 20 min. The samples were incubated with Ki67 mouse monoclonal antibody (1:200, Dako, Glostrup, Denmark) overnight at 4 8C, followed by peroxidaseconjugated donkey anti-mouse IgG (1:400, Sigma-Aldrich) as the secondary antibody. Peroxidase activity was detected using Vector NovaRED (Vector Laboratories), followed by counterstaining with Gill's hematoxylin (Vector Laboratories).
Statistical analysis
Number of de novo formed tubules and percentage of tubules supporting spermatogenesis per group (meanGS.D.) were compared using Kruskal-Wallis, P!0.05 was considered statistically significant. Student's t-test with P!0.05 was used to test for statistical significance between groups from the VEGFA experiment.
Image analysis
All sections were analysed using a Zeiss microscopy AxioImager M2 equipped with a CCD camera and controlled with AxioVision 4.8 software.
Results
Effect of germ cell number and extracellular matrix
Based on immunocytochemistry for the detection of UCHL1, GATA4, P450c17 and alpha smooth-muscle actin, the cell suspension used in groups 1, 2, and 4 contained a meanGS.D. of 3.1G1.1% undifferentiated spermatogonia, 72.8G14.6% Sertoli, 5G0.3% Leydig, and 4.4G2.8% peritubular myoid cells, in group 3 the germ cell population was adjusted to 25% undifferentiated spermatogonia, the other cell types were present in a concentration of 33.7G11.8% Sertoli, 10.7G2 Leydig, and 3.3G2.2% peritubular myoid cells. The method used to attain enrichment of spermatogonia also provided a twofold increase in the Leydig cell population, probably due to the lower adherence of this cell type to plastic (Vernon et al. 1991) . From 32 grafted recipients, three did not survive up to the final end point of analysis at 40 weeks, thus grafts were not recovered. The percentage of grafts recovered from both time points that developed de novo formed tubules were 79% for group 1 (control), 70% for group 2, 67% for group 3, and 58% for group 4 (Table 1).
Recovered grafts that did not develop into organised tubules were not included in further analysis.
Immunohistochemical identification of undifferentiated spermatogonia, seminiferous tubules formed and the presence of a functional niche supporting proliferation and development of spermatogenesis was carried out in cross sections at two time points of analysis. After 24 weeks of grafting, de novo formed seminiferous tubules resembled the morphology of prepubertal testis and the spermatogenic efficiency was determined as percentage of de novo formed tubules containing spermatogonia along the basement membrane per graft (Fig. 4) . After 40 weeks of cell grafting, spermatogenic efficiency was determined by the percentage of seminiferous tubules supporting germ cell differentiation (Fig. 5) .
Grafts recovered from all groups displayed large variance within group. The meanGS.E.M. of de novo formed tubules per graft was as follows: group 1 (control): 142G49, group 2: 267G70, group 3: 183G 51, and group 4: 67G16. The number of de novo formed tubules was significantly lower (P!0.05) in group 1 (control; 50!10 6 ) than in group 2 (50!10 6 in MRGF), when the same number of cells was grafted but without the addition of Matrigel as a supporting scaffold. Group 2 (50!10 6 in MRGF) and group 4 (10!10 6 in MRGF) were also significantly different, both groups had cells grafted under the same conditions mixed in Matrigel, but they differed in number of cells injected, so we inferred that the amount of cells influenced the number of tubules formed. No significant difference was detected between group 1 (control) and groups 3 and 4, and between group 3 (10!10 6 cells containing 25% spermatogonia) and group 4 (10!10 6 in MRGF). The meanGS.E.M. of spermatogenic efficiency measured in groups 1, 2, 3, and 4 was 15G2, 32G3, 31G5 and 39G7% respectively. The control group was significantly less efficient (P!0.05) than all other groups when formation of a functional niche was measured, no significant difference was detected amongst the other groups. Based on our results, the enrichment of germ cells in the cell suspension grafted did not increase the number of tubules supporting spermatogenesis (Table 1) .
Effect of VEGF165
Based on the results of the first set of experiments, we established group 4 (10!10 6 cells in MRGF) to be used as the standard protocol to investigate the effect of VEGF165 in de novo morphogenesis of the testis tissue.
Thirty-five out of 36 grafts were recovered from the VEGF165-treated group and 12 out of 12 were recovered from control grafts. From all grafts recovered, 92% of grafts from the VEGF165-treated group and 75% from the control group (PZ0.13) were organised as de novo formed testis tissue; grafts which did not develop into testis tissue were constituted mainly of Matrigel and were not analysed.
Immunohistochemistry for detection of UCHL1 and alpha smooth muscle actin from all recovered grafts demonstrated that the number of blood vessels or seminiferous tubules formed did not differ significantly between treated and control groups: 50.0G3.7 vs 49.8G6.2 and 78.2G9.7 vs 100.8G23 (meanGS.E.M.) respectively. However, when analysing the spermatogenic efficiency between de novo formed tubules, VEGF165-treated grafts displayed higher percentage of seminiferous tubules containing spermatogonia per graft than that of the control: 18.6G2.2 vs 11.3G3.3% (P!0.05) (Fig. 6) . Table 2 summarises the results.
To investigate how the addition of VEGF165 benefited the spermatogenic efficiency in the treated group, apoptosis and proliferation assays were carried out. TUNEL assay labeled very few apoptotic cells in recovered cell aggregates and in 10-week-old testis tissue used as a positive control, and there was no difference in the percentage of de novo tubules with apoptotic cells between the control and VEGF165-treated groups.
To analyse proliferation in VEGF165-treated vs control groups, we measured percentage of de novo formed tubules supporting proliferation (51.6G7.9 vs 39.5G 12.7) and ratio of proliferating spermatogonia to Sertoli cells (0.40G0.11 vs 0.12G0.06). Both parameters did not differ significantly; however, there was a trend with the VEGF165-treated group having a higher ratio of proliferating spermatogonia to proliferating Sertoli cell (PZ0.09). There was a significantly higher number of proliferating cells per tubule (2.3G0.2 vs 1.8G0.1; P!0.05) in the VEGF165-treated group compared with the control group (Fig. 7) .
Discussion
De novo morphogenesis of testis tissue is a unique assay which allows manipulation of cells before grafting and enables the recovery of cells in further phases of spermatogenesis. This bioassay can overcome existing challenges to study testicular morphogenesis and the SSC niche, such as the difficult access to the testis during different stages of development and to maintain and study larger animal models. However, the majority of existing reports is descriptive and protocols used differ in number of cells grafted, recovery times and the use of cell pellets or combination with extracellular matrix.
Despite the disparity amongst protocols, all groups described low numbers of tubules with spermatogenesis in the de novo formed tissue. Most of the tubules formed were constituted only by Sertoli cells. The low efficiency observed can be attributed to several reasons: the testicular tissue contains low number of spermatogonia and SSC under physiological conditions (Toebosch et al. 1989) resulting in scarcity of spermatogonia in the transplanted pool of cells, the procedure is elaborate from the enzymatic digestion of the tissue to surgical grafting, creating a harsh environment prone to cell damage and loss. Then, after transplantation, cells must adapt and reconstitute their previous microenvironment and reestablish germ cell development. Therefore, our first aim was to test different protocols and different conditions in a large number of samples to characterise and optimise this bioassay. Specifically, we evaluated the role of the extracellular matrix, number of cells grafted and the enrichment of undifferentiated spermatogonia in the development of de novo formed testicular tissue.
The comparison between control (established from our previous report by Honaramooz et al. (2007) ) and all other groups provided insights into the influence of Matrigel and the quantity of cells in the system. We concluded that addition of Matrigel to the mixture enhances tubule formation and decreases the requirement for large numbers of donor cells, which is beneficial for future studies in animal models where the availability of donor tissue may be limited. The positive influence of Matrigel on the development of tissue from a smaller number of testicular cells is in accordance to what has been reported (Kita et al. 2007 , Watanabe et al. 2009 ). Similarly, this matrix has been used to support tumour growth or maintenance of pancreatic islets in xenogenic hosts (Ruggeri et al. 2002 , Dufour et al. 2005 .
The influence of number of cells grafted was determined comparing tubule formation when the same conditions were provided to different number of cells grafted; our results supported what has been previously hypothesised (Watanabe et al. 2009) , that the number of cells grafted are correlated with tubule formation.
Different from what was anticipated, however, the fivefold enrichment of spermatogonia did not enhance number of tubules supporting spermatogenesis. We must consider that this bioassay faces a large variability in the development of the recovered tissue and this might have hampered the detection of a significant difference. Nonetheless, we report that the limited availability of SSCs is not primarily responsible for the system's lower efficiency. However, addition of Matrigel to the cell pellet enhanced tubule formation and promoted the efficiency of de novo formed testis tissue, possibly by contributing to cell-to-cell contact while diminishing cell loss.
Optimisation of the method was the first step to validate de novo morphogenesis as functional bioassay to study morphogenesis and spermatogenesis as demonstrated with the experiment investigating the effects of VEGF165 on de novo formation of testis tissue.
It has already been demonstrated that during morphogenesis, VEGFA amongst other growth factors orchestrates cord and vasculature formation by promoting migration of cells including pre endothelial cells from the mesonephros to the developing gonads (Bott et al. 2006 , Cool et al. 2011 ; in our results we did not detect any improvement in neovascularisation or number of tubules formed by exogenous supplementation of VEGF165; we noticed a tendency in overall development and organisation as de novo formed testis tissue from recovered grafts in the treated group, but it was not significantly different. However, the higher percentage of tubules with spermatogonia in the VEGF165-treated grafts suggested a role for VEGF165 in testicular development and a protective effect against the transient hypoxia and/or excessive handling by which cells are exposed during the grafting process.
The protective mechanism of VEGFA has been described in the CNS and retina when cells face ischemic environments (Wick et al. 2002 , Saint-Geniez et al. 2008 . The ability to improve the adaptation of cells to a new environment by overexpression of VEGFA has been reported in xenotransplantation of pancreatic islet cells and when testis tissue was treated before xenografting (Caires et al. 2009 ).
Analysis of apoptotic (TUNEL) and proliferative cells (Ki67) was used to detect a potential mechanism underlying the observed differences in tubules with germ cells formed with or without VEGF165 treatment. Only few cells were labeled by TUNEL and there was no difference in the percentage of tubules with apoptotic cells between groups. It is possible that after 12 weeks, when grafts were recovered, the cells that were damaged by the procedure may be no longer detectable. 
